Analyst downgraded Resideo from Overweight to Neutral and set a new price target of $16.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 4/22/2025 | $16.00 | Overweight → Neutral | Analyst |
| 8/9/2024 | $25.00 | Outperform | Evercore ISI |
| 7/5/2023 | $22.00 | Overweight | JP Morgan |
| 11/2/2022 | $27.00 | Outperform → In-line | Imperial Capital |
| 2/16/2022 | $31.00 → $30.00 | Equal-Weight | Morgan Stanley |
| 10/6/2021 | $33.00 → $31.00 | Equal-Weight | Morgan Stanley |
| 9/21/2021 | $36.00 → $33.00 | Equal-Weight | Morgan Stanley |